Extracellular Matrix (ECM)

The extracellular matrix is everything cells secrete and then live inside: fibrillar collagens for tensile strength, elastin for recoil, proteoglycans such as aggrecan and decorin whose glycosaminoglycan chains hold water and regulate fibril assembly, and adhesive glycoproteins including fibronectin and laminin. It is not inert packing. Cells grip it through integrins and read its stiffness, and it stores signal: heparin-binding growth factors, VEGF isoforms and latent TGF-beta are sequestered in it and released by proteolysis or mechanical strain, so degrading matrix is itself a signalling event.

Turnover rates vary enormously and are more often assumed than measured. Matrix metalloproteinases and their tissue inhibitors set the balance in most tissues, but load-bearing collagen can be extraordinarily long-lived. Radiocarbon dating of human Achilles tendon against the atmospheric bomb pulse of the mid twentieth century indicates the core of the tendon is essentially not renewed after adolescence, with turnover confined largely to the periphery.

That finding limits what tracer studies can claim. Short-term stable isotope work measuring collagen synthesis after exercise samples a small, rapidly exchanging peripheral pool rather than the load-bearing core, so a rise in synthesis rate is not evidence the tendon is being rebuilt. It also means matrix damage in adult tendon is not straightforwardly reversible.

The phrase to distrust is matrix remodelling used as a benefit in itself. Remodelling has a direction. More deposition without organisation is fibrosis; more degradation without replacement is degeneration; and both can be described honestly as ECM remodelling in a marketing sentence. Any claim should specify which components changed, in what direction, and whether the mechanical result was measured at all.